Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Skin cancer, Kaposi sarcoma
Stage/Subtype:  classic Kaposi sarcoma
Trial Type:  Treatment
Results 1-4 of 4 for your search:
Start Over
Pomalidomide in Treating Patients with Kaposi Sarcoma with or without HIV
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-C-0047, NCI-2013-01525, 120047, P11847, PO-KS-NCI-0050, NCT01495598
Pegylated Liposomal Doxorubicin Hydrochloride and Bevacizumab in Treating Patients with Advanced Kaposi Sarcoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 09-C-0130, NCI-2013-01450, 090130, NCT00902239, P09493, NCT00923936
EphB4-HSA in Treating Patients with Kaposi Sarcoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AMC-096, NCI-2015-00052, 096, NCT02799485
Pembrolizumab in Treating Patients with HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CITN-12, NCI-2015-01906, NCT02595866
Start Over